España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Jonathan Komp
The Canada Goose Story Isn't Broken, But There Is Elevated Risk
Peloton Shares Fall On Slowing Revenue, Growing Cash Burn
Sell-Side Likes Peloton's Winning First Quarter As Public Company
Peloton Shares Fall On Slowing Revenue, Growing Cash Burn
Sell-Side Likes Peloton's Winning First Quarter As Public Company
What The Street Thinks Of Under Armour's Q3 Beat As Accounting Investigation Continues
'Significant Risk': Under Armour Analysts On Federal Investigation Of Apparel Company's Accounting
What The Street Thinks Of Under Armour's Q3 Beat As Accounting Investigation Continues
|
'Significant Risk': Under Armour Analysts On Federal Investigation Of Apparel Company's Accounting
|
Peloton's Worth A Ride, Baird Says In Bullish Initiation
|
Crocs Could Pull Off 10-15% Earnings Upside, Baird Says In Upgrade
|
Read More...
Jonathan Komp Recent News
Zumiez Sticks Q1 Print: Analyst Says Skate Segment 'Somewhat Inexplicably Turned Positive'
|
Should Investors Buy The Dip In Canada Goose?
|
Baird Remains Confident In Nike, Prefers Foot Locker
|
Baird Names Canada Goose A 'Fresh Pick' Ahead Of Q3 Print
|
Baird Names Wolverine World Wide As Positive Fresh Pick
|
Canada Goose Heats Up After Q2 Sales Beat: A Sell-Side Roundup
|
Nike To Report Q1 Results After Kaepernick Ad Launch: A Sell-Side Preview
|
Baird Downgrades Duluth Holdings After 40% Gain
|
Baird Expects Nike To Reach North American Inflection With New Products
|
Baird Says Canada Goose Sell-Off Is Unwarranted, Upgrades To Outperform
|
Could Under Armour Have Its Fundamentals On Track In Less Than A Year?
|
A Post-Sneaker World: How 'Small' Footwear Brands Are Beating The Giants
|
Your End-Of-Year Guide To Apparel, Footwear, Fitness Stocks
|
Nike Ahead Of Investor Day: Is This The Bottom You've Been Waiting For?
|
Under Armour's ArmourBox Subscription Service, Reviewed
|
The History Between Deckers And Marcato
|
Nike Sell-Side Roundup: Staying Bullish Is The Right Foot Forward
|
Nike Negativity Could Spread To Retailers
|
Finish Line's Quarterly Pre-Announcement Complicates Footwear Story As Analysts Revisit Sector
|
Despite The Noise: Athletic Trends Can Return To Growth
|
This Analyst Is 'Throwing In The Towel' On Foot Locker
|
Caution Suggested Ahead Of Foot Locker Earnings
|
Taking A Deep Dive Into Canada Goose's First Publicly Reported Financial Statements
|